Primary |
Onychomycosis |
47.6% |
Product Used For Unknown Indication |
17.0% |
Fungal Infection |
8.4% |
Tinea Pedis |
4.8% |
Nail Infection |
4.3% |
Fungal Skin Infection |
1.9% |
Hypertension |
1.9% |
Drug Use For Unknown Indication |
1.8% |
Hypothyroidism |
1.7% |
Contraception |
1.5% |
Dementia Alzheimer's Type |
1.3% |
Dermatophytosis |
1.1% |
Back Pain |
0.9% |
Depression |
0.9% |
Nail Tinea |
0.9% |
Tinea Cruris |
0.9% |
Antifungal Treatment |
0.8% |
Tinea Infection |
0.8% |
Rash |
0.7% |
Trichophytosis |
0.7% |
|
Dysgeusia |
8.6% |
Suicidal Ideation |
6.6% |
Depression |
6.2% |
Rash |
6.2% |
Ageusia |
5.4% |
Cutaneous Lupus Erythematosus |
5.4% |
Hearing Impaired |
5.4% |
Drug Interaction |
5.1% |
Hepatitis |
5.1% |
Visual Impairment |
5.1% |
Deafness |
4.7% |
Weight Decreased |
4.7% |
Pancreatitis |
4.3% |
Panic Attack |
4.3% |
Paraesthesia |
4.3% |
Skin Exfoliation |
4.3% |
Urticaria |
3.9% |
Cholestasis |
3.5% |
Metrorrhagia |
3.5% |
Rhabdomyolysis |
3.5% |
|
Secondary |
Onychomycosis |
15.9% |
Fungal Infection |
13.6% |
Drug Use For Unknown Indication |
9.3% |
Aortic Valve Replacement |
7.5% |
Product Used For Unknown Indication |
7.5% |
Systemic Mycosis |
6.1% |
Lyme Disease |
5.6% |
Trichophytosis |
5.6% |
Hypertension |
4.2% |
Nail Infection |
3.3% |
Nail Tinea |
2.8% |
Tuberculosis |
2.8% |
Blood Cholesterol Increased |
2.3% |
Blood Pressure Increased |
2.3% |
Depression |
2.3% |
Schizoaffective Disorder Bipolar Type |
2.3% |
Immunosuppressant Drug Therapy |
1.9% |
Reflux Oesophagitis |
1.9% |
Analgesia |
1.4% |
Diabetes Mellitus |
1.4% |
|
Drug Interaction |
10.9% |
Septic Shock |
9.1% |
Cerebrovascular Accident |
7.3% |
Cutaneous Lupus Erythematosus |
7.3% |
Depression |
7.3% |
Tremor |
7.3% |
Bone Marrow Necrosis |
5.5% |
Rhabdomyolysis |
5.5% |
Weight Increased |
5.5% |
Extrapyramidal Disorder |
3.6% |
Hepatitis Acute |
3.6% |
Hyperhidrosis |
3.6% |
Neutrophil Count Decreased |
3.6% |
Onychomycosis |
3.6% |
Polyneuropathy |
3.6% |
Rash |
3.6% |
Urinary Tract Infection |
3.6% |
Abdominal Discomfort |
1.8% |
Abortion Spontaneous |
1.8% |
Acute Generalised Exanthematous Pustulosis |
1.8% |
|
Concomitant |
Product Used For Unknown Indication |
19.6% |
Rheumatoid Arthritis |
12.3% |
Drug Use For Unknown Indication |
12.1% |
Hiv Infection |
5.9% |
Prophylaxis |
5.0% |
Hypertension |
4.9% |
Onychomycosis |
4.5% |
Pain |
4.5% |
Diabetes Mellitus |
4.0% |
Insomnia |
3.9% |
Osteoporosis |
3.3% |
Gastritis Prophylaxis |
3.0% |
Breast Cancer |
2.8% |
Depression |
2.5% |
Mycobacterium Avium Complex Infection |
2.5% |
Rash |
2.0% |
Abdominal Pain |
1.9% |
Arthralgia |
1.8% |
Vitamin Supplementation |
1.8% |
Crohn's Disease |
1.7% |
|
Rash |
8.1% |
Neoplasm Malignant |
7.1% |
Pulmonary Embolism |
7.1% |
Pyelonephritis Acute |
7.1% |
Renal Tubular Necrosis |
7.1% |
White Blood Cell Count Increased |
7.1% |
Pain |
6.1% |
Arthralgia |
5.1% |
Toxic Epidermal Necrolysis |
5.1% |
Acute Myeloid Leukaemia |
4.0% |
Aspartate Aminotransferase Increased |
4.0% |
Death |
4.0% |
Drug Ineffective |
4.0% |
Headache |
4.0% |
Visual Acuity Reduced |
4.0% |
Vomiting |
4.0% |
Femur Fracture |
3.0% |
Granulocytopenia |
3.0% |
Liver Injury |
3.0% |
Myalgia |
3.0% |
|
Interacting |
Onychomycosis |
43.5% |
Hypertension |
8.7% |
Mental Disorder |
8.7% |
Product Used For Unknown Indication |
8.7% |
Tinea Infection |
8.7% |
Fungal Infection |
4.3% |
Hypothyroidism |
4.3% |
Intraocular Pressure Increased |
4.3% |
Nail Infection |
4.3% |
Schizoaffective Disorder |
4.3% |
|
Drug Interaction |
33.3% |
Persecutory Delusion |
13.3% |
Aspartate Aminotransferase Increased |
6.7% |
Delusion |
6.7% |
Hallucination |
6.7% |
Hypoglycaemia |
6.7% |
Ocular Hyperaemia |
6.7% |
Off Label Use |
6.7% |
Onychomycosis |
6.7% |
Tachycardia |
6.7% |
|